Page last updated: 2024-08-26

cobalt and mdv 3100

cobalt has been researched along with mdv 3100 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chau, CH; Fernandez, EV; Figg, WD; Ley, AM; Price, DK; Reece, KM; Sissung, TM; Troutman, SM	1

Other Studies

1 other study(ies) available for cobalt and mdv 3100

Article	Year
Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells. Molecular pharmacology, 2015, Volume: 87, Issue:6 Topics: Antineoplastic Agents; Benzamides; Cell Hypoxia; Cell Line, Tumor; Cobalt; Dihydrotestosterone; Disulfides; Drug Synergism; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indole Alkaloids; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Transcription, Genetic	2015

Article

Year

Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.

Molecular pharmacology, 2015, Volume: 87, Issue:6

Topics: Antineoplastic Agents; Benzamides; Cell Hypoxia; Cell Line, Tumor; Cobalt; Dihydrotestosterone; Disulfides; Drug Synergism; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indole Alkaloids; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Transcription, Genetic

2015